Does Midi Prescribe Veozah? Yes — Here’s Exactly What That Means for You

Does Midi prescribe Veozah?

Yes. Midi Health publicly lists fezolinetant — sold under the brand name Veozah — as a non-hormonal prescription option for hot flashes and night sweats. Midi even names it on its cancer-survivorship care page, alongside gabapentin and certain antidepressants, for women who can’t use hormones. So Midi is a reasonable place to ask. What Midi does not do is promise the prescription before a clinician reviews your case.

Let’s be clear about what “prescribe” really means here, because the difference protects you. There are three ways to read that word:

• Can evaluate you for Veozah — true. Midi’s clinicians can consider it.
• May prescribe Veozah if it’s right for you — also true. This is the honest framing.
• Will prescribe Veozah no matter what — not true, and you wouldn’t want a provider who worked that way.

We went and checked Midi’s own pages so you don’t have to open ten tabs. Here’s what we found, and when we last confirmed it.

What this does not mean: it doesn’t mean you’ll walk away with a prescription at the first visit. It doesn’t mean Veozah is right for everyone with hot flashes. And it doesn’t mean the visit fee covers the drug or the labs — those are separate costs we’ll break down below. For more on how Midi runs overall, see our Midi Health review.

Check Midi coverage before you book: Check Midi coverage →
A Midi clinician reviews your history and decides if Veozah fits. Coverage and copays vary by plan.

Is Midi the right place for you to ask about Veozah?

Midi is likely a good starting point if your main issue is menopause hot flashes or night sweats and you want a menopause-focused clinician to consider a non-hormonal prescription.It’s likely the wrong first step if you rely on Medicaid, need Medicare-covered visits through Midi, or have liver or kidney conditions that call for closer in-person care.

You know your situation better than any article. So find yourself in one of these two lists.

If you’re nodding along to the second list, don’t force it. And if you’re honestly not sure whether you need Veozah, hormone therapy, a vaginal estrogen for dryness, or a different non-hormonal medicine, don’t guess your way into a paid visit.

That’s exactly what our free matching tool is for. Find My HRT Path asks about your symptoms, your history, your state, and your insurance, then points you to the right next step — and flags when online care isn’t the right starting point at all. Because it asks about your health, it runs under our consumer-health-data and privacy policy.

Not sure Veozah is your path? Get your personalized plan with Find My HRT Path →
It matches your situation to the right step in a couple of minutes — no diagnosis, no pressure.

What is Veozah — and is it the same as HRT?

Veozah (fezolinetant) is not hormone therapy. It’s a non-hormonal, FDA-approved pill for moderate-to-severe vasomotor symptoms — the medical name for hot flashes and night sweats — due to menopause. It works on a switch in the brain (called the NK3 receptor) that helps control body temperature. That’s why it appeals to women who’ve been told they can’t take estrogen, including some breast cancer survivors, or who simply don’t want hormones. See our full Veozah guide for the complete picture, or our non-hormonal menopause treatments hub for other options.

Here’s the plain-English science. During menopause, falling estrogen throws off the brain’s thermostat. Veozah calms that signal at the source. It’s one pill, once a day.

Does it work? Yes, for many women. In two 12-week studies of more than 1,000 women (the SKYLIGHT trials), women on Veozah had about 2 to 3 fewer moderate-to-severe hot flashes a day than women on a placebo — a dummy pill (per the FDA label). Astellas, the maker, reports that at 12 weeks women taking Veozah had 63% fewer hot flashes, versus 42% on placebo. Some women notice a difference within the first week. Studies followed women taking it for up to a year.

Now the honest nuance most pages skip. An independent value review from the group ICER found the improvement was real and statistically solid — but on some measures it didn’t quite clear the bar researchers call a “minimum clinically important difference” (ICER, 2023). Translation: Veozah genuinely helps many women, but it’s not magic, and how much you’dfeel it varies. That’s exactly the kind of thing to talk through with a clinician.

The one thing to get straight: Veozah is aimed at hot flashes and night sweats. It’s not a fix for every menopause symptom. Here’s a quick map of where it helps and where it doesn’t — worth a look before you book, so you ask about the right things.

And here’s how Veozah stacks up against hormone therapy in plain terms.

The Menopause Society still calls hormone therapy the most effective treatment for hot flashes for women who can safely use it. Non-hormonal options like Veozah exist for everyone else — and for women who just prefer to skip hormones. Neither is automatically “better.” It depends on you. See our full Veozah vs. HRT comparison for cost, safety, and best-fit details.

Source: The Menopause Society, 2023 Nonhormone Therapy Position Statement.

The liver warning you need to understand before you start Veozah

Veozah carries the FDA’s strongest warning — a “boxed warning” — for rare but serious liver injury, added on December 16, 2024. Because of that, the label requires a liver blood test before you start, then repeat tests monthly for the first three months and again at months six and nine. This is the most important thing on this page, and it’s why how you get Veozah matters as much as whether you can. See our full Veozah liver warning breakdown for the complete monitoring schedule and warning signs.

A “boxed warning” is the most serious alert the FDA puts on a drug. It doesn’t mean the drug is off-limits. It means it must be used carefully, with monitoring. Here’s what the label actually requires, in plain terms.

The specific rule: you can’t start Veozah if your ALT or AST is at least twice the normal upper limit, or if your total bilirubin is at least twice the normal upper limit.

Signs of a liver problem — stop and call your clinician if you notice: unusual tiredness, nausea, vomiting, loss of appetite, belly pain (especially on the upper right side), swelling in your belly, itching, yellowing of the skin or eyes, dark urine, or pale stools.

Veozah is also notfor everyone. The label says don’t take it if you have cirrhosis (severe liver scarring), severe or end-stage kidney disease, or if you take certain medicines called CYP1A2 inhibitors — drugs that can raise Veozah levels in your body. That’s a big reason to bring your full medicine list to any visit.

Our original check: does Midi’s setup actually fit this drug?

This is the question no other page answers. A boxed-warning drug needs baseline labs, repeat labs, and a clinician who stays in the loop. So we mapped what Veozah’s FDA label demands against how Midi actually runs — line by line. We built this table; you won’t find it anywhere else.

Veozah’s FDA-required monitoring vs. how Midi’s care model handles it (left column: FDA/DailyMed labeling; right columns: Midi’s own pages. Last verified: July 2026.)

The takeaway: Midi’s “we order labs and keep following up” approach is a genuine match for a drug that requires exactly that.

Now the one honest catch about Midi. Midi will not call in a Veozah prescription after a quick online form — no visit, no labs, no prescription. If your only goal is to get the pills as fast and cheap as humanly possible, a bare-bones “just fill out a questionnaire” service will feel easier, and for that single goal, it is. But Veozah has the FDA’s most serious liver warning, and the label requires that testing before and after you start. Because Midi runs a real visit and orders those labs, you get the monitoring a boxed-warning drug is supposed to have. In other words, the “friction” isthe safety. If speed-at-any-cost is truly all you want, that’s a fair choice — but a lower-cost non-hormonal route may be generic antidepressants or gabapentin, which we cover further down.

Because Veozah needs real monitoring, start with a provider that orders the labs: Ask Midi about Veozah →
Bring your medicine list and ask what liver tests you’d need before and after starting.

What Veozah really costs when you go through Midi

There are two separate bills: the Midi visit and the Veozah prescription. Astellas lists Veozah’s price at $566 a month without insurance, but the average out-of-pocket cost drops to about $42 a month with commercial insurance. Midi’s own visit — a different charge — is listed at $250 for a first self-pay visit, or a copay if you’re insured. The drug is usually the bigger number, and it depends heavily on your coverage. Let’s untangle it. (See our dedicated Veozah cost without insurance guide for the full pharmacy-side breakdown.)

The Veozah drug cost (a pharmacy question, separate from Midi)

• List price: $566/month for a 30-day supply, per Astellas (list-price data exported January 2025). There’s no generic version, and none is expected soon — patent protections run into the 2030s — so the price stays high.
• Real pharmacy cash prices can run even higher than the list price at some pharmacies. SingleCare recently showed an average retail price around $772 and discount-card prices from roughly $474 to $603 — but these change daily, so check on the day you fill.
• With commercial insurance, Astellas reports the average out-of-pocket cost is about $42/month.
• The savings card: if you have commercial insurance, you may pay $0 the first month and about $30 per refill, up to $4,000 a year. This card is not valid if you have Medicare, Medicaid, or pay cash. See our Veozah savings card guide for the fine print.
• If you’re uninsured, the Astellas Patient Assistance Program can provide Veozah at $0 for people who qualify (call 1-866-239-1637).

The Midi visit cost (separate from the drug)

• With insurance: most insured patients pay a copay; Midi is in-network with most PPO plans.
• Self-pay: Midi’s pricing page lists $250 for a first visit and $150 for follow-ups.
• Important: the visit fee does not include your labs or your medication.

Here’s the whole picture in one place — four real situations, so you can find yours. We assembled this; no single competitor page combines it.

What Veozah through Midi really costs, by situation (estimates from Midi + Astellas + pharmacy sources; confirm your exact numbers at checkout and with your plan. Last verified: July 2026.)

Average out-of-pocket figures by insurance type are Astellas-reported, using data through early 2025.

One detail that trips people up: on Medicaid, Veozah itself is nearly free — about $2 a month on average. But Midi cannot treat Medicaid or Medi-Cal patients, even if you offer to pay cash. So the cheap drug and Midi don’t line up. If you’re on Medicaid, you’ll get Veozah far more cheaply through a Medicaid-participating clinician than through Midi.

Questions to ask before you pay for anything:

• “Does my plan cover Midi Health for menopause visits?”
• “Is Veozah (fezolinetant) on my pharmacy’s covered list?”
• “Does it need prior authorization or step therapy?”
• “Are my liver labs covered, and where do I get them drawn?”
• “Can I use the manufacturer savings card with my plan?”

See what your visit would cost: Check Midi coverage →
Two bills, not one: the visit and the drug. Check both before you book.

Can you get Veozah online through Midi?

Yes — you can ask a licensed Midi clinician about Veozah entirely online, through a video visit. But Veozah is a prescription drug, not something you buy over the counter, so a clinician still has to evaluate you and order the required liver labs first. Online care handles the visit, the lab orders, and the prescription; a local lab draws your blood, and your pharmacy fills the pill.

Here’s how the online path actually works with Midi:

1. You book a virtual visit and fill out your health history.
2. You meet a menopause-trained clinician by video and bring up Veozah.
3. If it’s appropriate, the clinician orders your baseline liver labs.
4. You get your blood drawn at a local lab (Midi generally uses Labcorp).
5. If your labs are clear, the prescription goes to your pharmacy.
6. You keep up the follow-up liver tests at months 1, 2, 3, 6, and 9.

Telehealth is well-suited to menopause care, because most of what a clinician needs is a real conversation and the right labs — not an in-person exam. The one thing online care can’t skip for this drug is the liver monitoring. A provider who orders and tracks those labs is doing it right.

Will your insurance cover Veozah through Midi?

Coverage comes in two layers: whether your plan covers the Midi visit, and whether your pharmacy benefit covers the Veozah drug. Midi is in-network with most commercial PPO plans, but Veozah coverage often requires prior authorization — and Midi can’t take Medicaid at all or bill Medicare. These are the details that decide whether this route is smooth or a dead end for you. See our Veozah insurance coverage guide and prior authorization walkthrough for the appeal steps.

Two quick terms worth knowing:

• Prior authorization means your insurer wants your clinician to explain why you need the drug before they’ll pay. Veozah often requires this.
• Step therapy means the plan may want you to try a cheaper option first.

Astellas reports that about 64% of people with commercial insurancehave coverage for Veozah — though often with prior authorization or step edits. Here’s how the two layers line up.

Does Midi take Medicare or Medicaid for Veozah?

No. Midi is not covered by Medicare — Medicare members can only see Midi as self-pay, and can’t file any claims — and Midi does not treat Medicaid or Medi-Cal patients at all, even self-pay. If that’s your coverage, Midi isn’t your route to Veozah. Veozah itself is often well-covered by these programs, so a Medicaid-participating clinician or an in-person provider will usually be the cheaper, smoother path. See our Veozah Medicare coverage guide for the Part D specifics.

If your commercial plan says no, don’t give up on the spot. Ask your clinician and insurer about an appeal, prior authorization, the savings card (commercial insurance only), or a different non-hormonal medicine.

Source: Medicare.gov, 2026 Part D out-of-pocket cap.

How to ask Midi about Veozah (what to prepare, and what to say)

The best way to ask isn’t “Can I get Veozah?” It’s asking a clinician whether your symptoms, history, medicines, and insurance make Veozah a reasonable option to consider — and what labs it would take.Walk in prepared, and you’re far more likely to leave with a clear plan, whether that’s Veozah, a different option, or a next step.

Bring this to your visit:

• How often your hot flashes or night sweats hit, and how bad they are
• Your menopause status and age
• Every medicine and supplement you take
• Any liver or kidney history
• Any cancer history or reasons you’ve been told to avoid hormones
• Any menopause treatments you’ve already tried
• Your insurance and pharmacy info, if you have it
• Any recent liver blood test results

Then, use these words. Copy them if it helps — they take the pressure off and get you a straight answer.

Ready to ask? Book your Midi visit and ask about Veozah →
Bring your medicine list. The goal isn’t a same-day prescription — it’s a clear plan.

What if Veozah — or Midi — isn’t right for you?

A “no” on Veozah doesn’t mean you’re out of options, and Midi isn’t the only door to it.Depending on your symptoms and history, a clinician might suggest a different non-hormonal medicine, hormone therapy, a local vaginal treatment, or in-person care. And if Midi doesn’t fit your insurance or state, other providers can still help you ask about Veozah.

Why a clinician might say “not yet” or “not this”:

• You need labs first
• One of your medicines could clash with Veozah
• You have a liver or kidney concern
• Your symptoms point somewhere else
• Insurance denied it or wants prior authorization
• Your case is safer handled in person

Other treatments to ask about (some cost far less):

Generic price ranges via pharmacy pricing sources; these are different medicines studied in separate trials, not head-to-head against Veozah — ask a clinician which fits you. See our Veozah vs. paroxetine, Veozah vs. venlafaxine, and Veozah vs. gabapentin comparisons for the details.

Other ways to get Veozah prescribed (if Midi isn’t your fit):

If your head is spinning about which lane is yours, that’s normal — and it’s a two-minute fix.

Not sure which option fits? Use Find My HRT Path →
Get a personalized next step before choosing a provider, a drug, or in-person care.

What Midi patients say about the experience

These are patient comments published on Midi’s own website. They describe the care experience — not proof that Veozah works, and not a promise that your results will match.We share them because “is this legit and easy?” is a real question, and hearing from patients helps. We don’t use testimonials to make medical claims, and we don’t run star ratings we didn’t earn.

“Midi was incredibly easy. I signed up and had a visit the next day.”

“[Midi's clinicians are real specialists] who work with women day in and day out.”

Source: Midi’s published patient testimonials.

Take these for what they are: a sense of the front-door experience, not a guarantee about any medication or outcome. For more patient-reported detail across all of Midi’s services, see our Midi Health review and our Veozah patient reviews roundup.

What we actually verified about Midi and Veozah

We showed our work. We review every provider with The HRT Index Verification Standard— the same five checks, in the same order, every time: clinical legitimacy, care quality, medication fit, price transparency, and access. Here’s what we confirmed, split by source type so you can see exactly where each fact comes from.

Provider-stated (Midi’s own pages)

• Midi lists fezolinetant (Veozah) among non-hormonal options for hot flashes.
• Midi frames it as clinician-decided care, not guaranteed access.
• Midi is in-network with most PPO plans; self-pay is $250 initial / $150 follow-up; it can’t bill Medicaid/Medi-Cal and isn’t covered by Medicare (self-pay only, no claims).
• Midi says it’s available in all 50 states and generally orders labs through Labcorp.

Regulatory label (FDA / DailyMed)

• Veozah’s boxed warning for rare serious liver injury (added December 16, 2024).
• The liver-testing schedule: before starting, monthly for the first 3 months, then months 6 and 9.
• Contraindications: cirrhosis, severe/end-stage kidney disease, and CYP1A2 inhibitors.

Manufacturer cost data (Astellas)

• List price $566/month; average out-of-pocket ~$42 commercial, ~$55 Medicare, ~$2 Medicaid (data through early 2025).
• Savings card ($0 first month / ~$30 refills, commercial insurance only) and a patient assistance program for the uninsured.

Not verified firsthand

• We did not sign up for a visit or obtain a prescription ourselves — this is documentary verification from primary and provider sources, not a personal account.
• Still to confirm: Midi’s exact current prices at checkout, whether Veozah is prescribable in every Midi state, and whether Midi currently prescribes Lynkuet.

Who made this and why: This page was written by The HRT Index editorial team — the independent menopause HRT decision layer for women — to help you decide whether Midi is a realistic starting point for Veozah beforeyou pay for a consult. It’s editorial research, not medical advice, and it was not reviewed by a clinician. We’re transparent about what we checked and when, and we re-verify pricing monthly and medical and regulatory facts quarterly.

Frequently asked questions about Midi and Veozah

The short version: Midi lists Veozah as a non-hormonal hot-flash option, but a prescription depends on a clinician’s review, liver testing, your other medicines, and your insurance. These answers cover the follow-ups most likely to send you back to searching.

So — does Midi prescribe Veozah?

Yes, when a clinician decides it’s right, with the liver monitoring the drug requires. If your main problem is moderate-to-severe hot flashes and you want a non-hormonal option reviewed by a menopause-focused clinician, Midi is a solid place to start. If you’re unsure whether Veozah, hormone therapy, a local treatment, or in-person care fits you, don’t guess. Take our free Find My HRT Path match. It takes about two minutes and gives you a personalized starting point — including a flag if your situation calls for in-person care — before your first consult.

The HRT Index is the independent decision resource for online menopause and HRT care. This page is educational only and is not medical advice. FDA-approved and compounded medications are always labeled distinctly here, and compounded options are never implied to be safer than, more natural than, or equivalent to FDA-approved medication. For any medical decision, talk with a licensed clinician. Last verified: July 2026.

Sources (verified July 2026)

• Midi Health — cancer-survivorship care page: joinmidi.com/cancer
• Midi Health — Pricing & Insurance: joinmidi.com/pricing-insurance (self-pay $250/$150; PPO in-network; no Medicaid; Medicare self-pay only)
• Midi Health support — “How much will my appointment cost?”: joinmidi.zendesk.com (visit excludes labs/meds) and “Can Midi clinicians order blood tests?” (generally Labcorp)
• U.S. FDA — Drug Safety Communication, updated Dec 16, 2024 (boxed warning; monitoring before starting, monthly ×3, then months 6 and 9)
• DailyMed — VEOZAH label (baseline ALT/AST/ALP + total & direct bilirubin; do not start if ALT/AST ≥2× ULN or total bilirubin ≥2× ULN; contraindications: cirrhosis, severe/end-stage renal disease, CYP1A2 inhibitors; liver-injury symptoms)
• Cost: veozahcost.com (list $566/month; avg out-of-pocket $42 commercial / $55 Medicare / $2 Medicaid, data through early 2025); veozah.com/savings (savings card; 64% commercial covered lives, with/without restrictions); SingleCare (retail ~$772; coupons ~$474–$603); VEOZAH Support Solutions (patient assistance)
• Efficacy: SKYLIGHT 1 (Lancet) and SKYLIGHT 2 (J Clin Endocrinol Metab); DailyMed (Week-12 effect sizes); ICER value review (MCID nuance); The Menopause Society 2023 Nonhormone Therapy Position Statement
• Medicare: Medicare.gov (2026 Part D out-of-pocket cap ~$2,100)
• Lynkuet: Bayer (elinzanetant FDA approval, October 2025)
• Generic price ranges: pharmacy pricing sources (e.g., Medfinder)